Ecor1-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1618567932
Accession Number
0000935836-25-000338
Form Type
13F-HR
Manager Name
Ecor1-Capital
Data Enrichment
93% identified
41 identified3 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 2 of 3
Beam Therapeutics Inc.
Shares:526.7K
Value:$10.3M
MBX Biosciences, Inc.
Shares:1.3M
Value:$9.3M
Ginkgo Bioworks Holdings, Inc.
Shares:1.5M
Value:$8.3M
Replimune Group, Inc.
Shares:850.3K
Value:$8.3M
BICYCLE THERAPEUTICS PLC
Shares:910.0K
Value:$7.7M
Day One Biopharmaceuticals, Inc.
Shares:862.1K
Value:$6.8M
Verve Therapeutics, Inc.
Shares:1.3M
Value:$5.7M
Adaptimmune Therapeutics PLC
Shares:27.4M
Value:$5.4M
GALAPAGOS NV
Shares:155.0K
Value:$3.9M
Whitehawk Therapeutics, Inc.
Shares:2.1M
Value:$3.7M
Atara Biotherapeutics, Inc.
Shares:573.2K
Value:$3.4M
Solid Biosciences Inc.
Shares:744.5K
Value:$2.8M
Keros Therapeutics, Inc.
Shares:187.5K
Value:$1.9M
67080N119
Shares:963.3K
Value:$1.7M
Relay Therapeutics, Inc.
Shares:641.4K
Value:$1.7M
Kalaris Therapeutics, Inc.
Shares:201.7K
Value:$1.6M
uniQure N.V.
Shares:135.0K
Value:$1.4M
Prime Medicine, Inc.
Shares:700.0K
Value:$1.4M
59267L107
Shares:50.0K
Value:$1.4M
TScan Therapeutics, Inc.
Shares:662.8K
Value:$914.7K